| http://www.w3.org/ns/prov#value | - Accordingly, administration of drugs with anti-inflammatory properties, such as statins or steroids, have been suggested to reduce the risk of major adverse cardiac events and ISR in the BMS era,31,32 especially in those patients with high inflammatory reactivity.29,32 Of note, the role of systemic anti-inflammatory therapies as adjuncts to the local effect of DES has not yet been tested.
|
